Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Abrdn Healthcare Opportunities Fund THQ

Set alert

Price alert · THQ

All alert types
18.75 USD +0.04 +0.19%

As of Nov 2, 9:32 AM ET

Bid
18.47 × 400
Ask
18.74 × 400
18.62 Day range 18.75
16.28 52-week range 20.39
YTD
-2.01%
1 year
+3.39%
Open
18.98
Prev close
18.71
Mkt cap
776.75M
Vol
4.63K
Avg vol
126.63K
EPS
-0.70
P/E
0.00
Div yield
0.00%
More statistics
Low
18.62
High
18.75
Forward P/E
0.00
Beta
0.00
Short ratio
0.15
Inst. own
20.76%
Dividend
1.35
Ex-div date
Oct 18, 2023
50-d avg
20.63
200-d avg
20.63
1y target
0.00

MAX chart

Chart tools
Interval
1m5m15m30m

Signals (69)
NameDateAgo
SMA: BullishOct 1, 20261 month ago
SMA: BearishSep 1, 20262 months ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishAug 1, 20263 months ago
MACD: Buy SignalMay 1, 20266 months ago
SMA: BullishApr 1, 20267 months ago
SMA: BearishMar 1, 20268 months ago
SMA: BearishMar 1, 20268 months ago
MACD: Sell SignalMar 1, 20268 months ago
SMA: BullishFeb 1, 20269 months ago
MACD: Buy SignalFeb 1, 20269 months ago
SMA: BullishNov 1, 20251 year ago
MACD: Sell SignalMay 1, 20251 year ago
SMA: BearishApr 1, 20251 year ago
SMA: BearishMar 1, 20251 year ago
SMA: BullishJan 1, 20251 year ago
SMA: BullishJan 1, 20251 year ago
SMA: BearishDec 1, 20241 year ago
SMA: BearishDec 1, 20241 year ago
SMA: BullishMay 1, 20242 years ago
SMA: BearishApr 1, 20242 years ago
SMA: BullishMar 1, 20242 years ago
MACD: Buy SignalFeb 1, 20242 years ago
SMA: BearishDec 1, 20223 years ago
SMA: BullishNov 1, 20224 years ago
SMA: BearishJun 1, 20224 years ago
MACD: Sell SignalFeb 1, 20224 years ago
SMA: BearishJan 1, 20224 years ago
RSI: OverboughtJul 1, 20215 years ago
RSI: OverboughtMay 1, 20215 years ago
SMA: BullishNov 1, 20206 years ago
SMA: BullishNov 1, 20206 years ago
SMA: BearishOct 1, 20206 years ago
SMA: BearishOct 1, 20206 years ago
MACD: Buy SignalMay 1, 20206 years ago
SMA: BullishApr 1, 20206 years ago
SMA: BullishApr 1, 20206 years ago
MACD: Sell SignalMar 1, 20206 years ago
SMA: BearishFeb 1, 20206 years ago
SMA: BearishFeb 1, 20206 years ago
SMA: BullishOct 1, 20197 years ago
MACD: Buy SignalOct 1, 20197 years ago
SMA: BullishSep 1, 20197 years ago
SMA: BearishAug 1, 20197 years ago
SMA: BearishJul 1, 20197 years ago
SMA: BullishJun 1, 20197 years ago
SMA: BullishJun 1, 20197 years ago
SMA: BearishApr 1, 20197 years ago
MACD: Sell SignalApr 1, 20197 years ago
SMA: BearishFeb 1, 20197 years ago
SMA: BullishJan 1, 20197 years ago
SMA: BullishJan 1, 20197 years ago
SMA: BearishDec 1, 20187 years ago
SMA: BearishDec 1, 20187 years ago
SMA: BullishJul 1, 20188 years ago
MACD: Buy SignalJun 1, 20188 years ago
MACD: Sell SignalMay 1, 20188 years ago
SMA: BearishMar 1, 20188 years ago
SMA: BearishFeb 1, 20188 years ago
SMA: BullishJan 1, 20188 years ago
SMA: BearishOct 1, 20179 years ago
SMA: BullishJun 1, 20179 years ago
SMA: BullishJan 1, 20179 years ago
SMA: BearishOct 1, 201610 years ago
SMA: BullishMay 1, 201610 years ago
RSI: OversoldFeb 1, 201610 years ago
SMA: BearishAug 1, 201511 years ago
SMA: BullishJul 1, 201511 years ago
SMA: BearishJun 1, 201511 years ago

Financial health

Altman Z-Score

1.73 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 3

Valuation

P/E -6.2×
FY 2016: 8.3×FY 2017: 8.0×FY 2018: 8.3×FY 2019: -17.3×FY 2020: 6.4×FY 2021: 4.8×FY 2022: -8.7×FY 2023: 13.3×FY 2024: 4.8×FY 2025: -6.2×
FY 2016 5y median 4.8× FY 2025
P/S -7.1×
FY 2016: 13.9×FY 2017: 7.9×FY 2018: 8.1×FY 2019: -18.0×FY 2020: 6.3×FY 2021: 4.8×FY 2022: 10.8×FY 2023: 8.7×FY 2024: 4.8×FY 2025: -7.1×
FY 2016 5y median 4.8× FY 2025
P/B 1.0×
FY 2016: 0.9×FY 2017: 0.9×FY 2018: 0.9×FY 2019: 0.9×FY 2020: 0.9×FY 2021: 1.0×FY 2022: 0.9×FY 2023: 0.8×FY 2024: 1.0×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
P/FCF 2023×
FY 2016: 48.8×FY 2017: 11.9×FY 2018: 7.7×FY 2019: 12.4×FY 2020: 11.8×FY 2021: 28.3×FY 2022: 13.5×FY 2023: 12.5×FY 2024: 11.7×FY 2025: 2023×
FY 2016 5y median 13.5× FY 2025
EV/EBITDA -8.2×
FY 2016: 11.1×FY 2017: 9.8×FY 2018: 10.0×FY 2019: -22.7×FY 2020: 0.0×FY 2021: 6.0×FY 2022: -11.6×FY 2023: 14.0×FY 2024: 5.6×FY 2025: -8.2×
FY 2016 5y median 5.6× FY 2025
EV/Sales -9.3×
FY 2016: 18.1×FY 2017: 10.0×FY 2018: 10.4×FY 2019: -23.6×FY 2020: 8.1×FY 2021: 5.9×FY 2022: 13.8×FY 2023: 11.5×FY 2024: 6.0×FY 2025: -9.3×
FY 2016 5y median 6.0× FY 2025
FCF Yield 0.0%
FY 2016: 2.0%FY 2017: 8.4%FY 2018: 13.0%FY 2019: 8.0%FY 2020: 8.5%FY 2021: 3.5%FY 2022: 7.4%FY 2023: 8.0%FY 2024: 8.6%FY 2025: 0.0%
FY 2016 5y median 7.4% FY 2025

Profitability

Gross Margin 112.8%
FY 2016: 78.7%FY 2017: 88.7%FY 2018: 88.0%FY 2019: 128.5%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 81.1%FY 2023: 84.7%FY 2024: 100.0%FY 2025: 112.8%
FY 2016 5y median 100.0% FY 2025
Operating Margin 113.9%
FY 2016: 167.9%FY 2017: 102.3%FY 2018: 104.2%FY 2019: 104.3%FY 2020: 98.5%FY 2021: 99.0%FY 2022: -118.5%FY 2023: 16.8%FY 2024: 107.0%FY 2025: 113.9%
FY 2016 5y median 99.0% FY 2025
Net Margin 113.9%
FY 2016: 167.9%FY 2017: 98.1%FY 2018: 98.1%FY 2019: 104.3%FY 2020: 98.5%FY 2021: 99.0%FY 2022: -124.0%FY 2023: 65.6%FY 2024: 99.2%FY 2025: 113.9%
FY 2016 5y median 99.0% FY 2025
ROE -15.5%
FY 2016: 11.0%FY 2017: 11.5%FY 2018: 10.8%FY 2019: -5.4%FY 2020: 13.9%FY 2021: 19.9%FY 2022: -10.3%FY 2023: 6.3%FY 2024: 20.1%FY 2025: -15.5%
FY 2016 5y median 6.3% FY 2025
ROIC -9.6%
FY 2016: 7.1%FY 2017: 7.9%FY 2018: 7.6%FY 2019: -3.4%FY 2020: 11.0%FY 2021: 16.2%FY 2022: -6.4%FY 2023: 1.1%FY 2024: 14.1%FY 2025: -9.6%
FY 2016 5y median 1.1% FY 2025
ROA -11.8%
FY 2016: 8.5%FY 2017: 9.0%FY 2018: 8.6%FY 2019: -4.1%FY 2020: 10.5%FY 2021: 15.7%FY 2022: -8.1%FY 2023: 5.0%FY 2024: 16.2%FY 2025: -11.8%
FY 2016 5y median 5.0% FY 2025

Growth (YoY)

Revenue -152.8%
FY 2016: 178.1%FY 2017: 88.3%FY 2018: -4.9%FY 2019: -141.1%FY 2020: 394.9%FY 2021: 66.0%FY 2022: -64.6%FY 2023: 15.7%FY 2024: 137.3%FY 2025: -152.8%
FY 2016 FY 2025
Operating Income -156.1%
FY 2016: 1864.8%FY 2017: 14.7%FY 2018: -3.2%FY 2019: -141.1%FY 2020: 378.7%FY 2021: 66.9%FY 2022: -142.3%FY 2023: 116.4%FY 2024: 1412.5%FY 2025: -156.1%
FY 2016 FY 2025
EPS (diluted) -160.7%
FY 2016: 167.1%FY 2017: 10.0%FY 2018: -1.7%FY 2019: -144.3%FY 2020: 379.2%FY 2021: 67.0%FY 2022: -144.4%FY 2023: 161.2%FY 2024: 257.8%FY 2025: -160.7%
FY 2016 FY 2025
Free Cash Flow -99.5%
FY 2016: 105.4%FY 2017: 335.4%FY 2018: 52.1%FY 2019: -43.6%FY 2020: 9.0%FY 2021: -47.9%FY 2022: 68.0%FY 2023: 0.5%FY 2024: 40.2%FY 2025: -99.5%
FY 2016 FY 2025

Financial Health

Current Ratio 6.9×
FY 2016: 0.2×FY 2017: 0.5×FY 2018: 138×FY 2019: 6.0×FY 2020: 0.6×FY 2021: 0.1×FY 2022: 2.2×FY 2023: 0.8×FY 2024: 16.3×FY 2025: 6.9×
FY 2016 5y median 2.2× FY 2025
Quick Ratio 6.9×
FY 2016: 0.2×FY 2017: -3.0×FY 2018: 23.7×FY 2019: -13.3×FY 2020: 0.6×FY 2021: 0.1×FY 2022: 2.2×FY 2023: -14.3×FY 2024: 16.3×FY 2025: 6.9×
FY 2016 5y median 2.2× FY 2025
Debt / Equity 0.3×
FY 2016: 0.3×FY 2017: 0.3×FY 2018: 0.3×FY 2019: 0.3×FY 2020: 0.3×FY 2021: 0.2×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA -2.0×
FY 2016: 2.5×FY 2017: 2.1×FY 2018: 2.2×FY 2019: -5.4×FY 2020: 0.0×FY 2021: 1.2×FY 2022: -2.5×FY 2023: 3.4×FY 2024: 1.1×FY 2025: -2.0×
FY 2016 5y median 1.1× FY 2025
Interest Coverage -8.9×
FY 2016: 29.6×FY 2017: 24.3×FY 2018: 17.1×FY 2019: -5.7×FY 2020: 25.1×FY 2021: 91.4×FY 2022: -21.5×FY 2023: 1.0×FY 2024: 13.7×FY 2025: -8.9×
FY 2016 5y median 1.0× FY 2025

Dividends

Dividend Yield 12.4%
FY 2016: 9.5%FY 2017: 7.3%FY 2018: 7.3%FY 2019: 7.8%FY 2020: 7.5%FY 2021: 6.0%FY 2022: 7.4%FY 2023: 8.0%FY 2024: 8.6%FY 2025: 12.4%
FY 2016 5y median 8.0% FY 2025
Payout Ratio -77.0%
FY 2016: 78.8%FY 2017: 58.3%FY 2018: 60.3%FY 2019: -134.1%FY 2020: 47.9%FY 2021: 28.6%FY 2022: -64.4%FY 2023: 105.7%FY 2024: 41.3%FY 2025: -77.0%
FY 2016 5y median 28.6% FY 2025

Annual · latest fiscal year ends 2025-09-30